Russ B. Altman, MD, PhD, is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science and past chairman of Bioengineering at Stanford University. His research applies computing (AI, data science and informatics) to problems relevant to molecular medicine—particularly understanding drug actions, interactions, efficacy and adverse effects. Dr. Altman is the founding PI of PharmGKB.org, and  co-leads an FDA-supported Center of Excellence in Regulatory Science & Innovation.  He is a member of the National Academy of Medicine, and is past-president of the International Society for Computational Biology and of the American Society for Clinical Pharmacology & Therapeutics. He has chaired the FDA Science Board, served on the NIH Director’s Advisory Committee, and co-chaired the IOM Drug Forum. He helps organize the Pacific Symposium on Biocomputing, and is the founding editor of the Annual Reviews of Biomedical Data Science.  He hosts a podcast “The Future of Everything.”